
Kenvue Inc. (NYSE:KVUE) interim CEO Kirk Perry met privately this week with Health Secretary Robert F. Kennedy Jr. to argue that there is no proven link between the popular pain reliever Tylenol and autism.
Kennedy is prepared to release a report later this month suggesting that acetaminophen, an active ingredient in Tylenol, used during pregnancy, could be a potential factor in neurodevelopmental disorders.